Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hermsen, B. B. J."'
Autor:
Marijnen, Mauritia C., Kamphof, Hester D., Damhuis, Stefanie E., Smies, Maddy, Leemhuis, Aleid G., Wolf, Hans, Gordijn, Sanne J., Ganzevoort, Wessel, Schaaf, J. M., de Boer, M. A., Zwart, J. J., Huisjes, A. J. M., Veerbeek, J. H. W., van Laar, J. O. E. H., Al‐Nasiry, S., Bremer, H. A., Hermsen, B. B. J., van de Nieuwenhof, H. P., Sueters, M., van der Ham, D. P.
Publikováno v:
BJOG: An International Journal of Obstetrics & Gynaecology; Jul2024, Vol. 131 Issue 8, p1042-1053, 12p
Autor:
Lof, P., van de Vrie, R., Korse, C. M., van Gent, M. D. J. M., Mom, C. H., Rosier - van Dunné, F. M. F., van Baal, W. M., Verhoeve, H. R., Hermsen, B. B. J., Verbruggen, M. B., Hemelaar, M., van de Swaluw, A. M. G., Knipscheer, H. C., Huirne, J. A. F., Westenberg, S. M., van der Noort, V., Amant, F., van den Broek, D., Lok, C. A. R.
Publikováno v:
Gynecologic oncology, 166(2), 284-291. Academic Press Inc.
Lof, P, van de Vrie, R, Korse, C M, van Gent, M D J M, Mom, C H, Rosier-van Dunné, F M F, van Baal, W M, Verhoeve, H R, Hermsen, B B J, Verbruggen, M B, Hemelaar, M, van de Swaluw, A M G, Knipscheer, H C, Huirne, J A F, Westenberg, S M, van der Noort, V, Amant, F, van den Broek, D & Lok, C A R 2022, ' Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital? ', Gynecologic Oncology, vol. 166, no. 2, pp. 284-291 . https://doi.org/10.1016/j.ygyno.2022.05.025
Gynecologic Oncology, 166(2), 284-291. Academic Press Inc.
Lof, P, van de Vrie, R, Korse, C M, van Gent, M D J M, Mom, C H, Rosier-van Dunné, F M F, van Baal, W M, Verhoeve, H R, Hermsen, B B J, Verbruggen, M B, Hemelaar, M, van de Swaluw, A M G, Knipscheer, H C, Huirne, J A F, Westenberg, S M, van der Noort, V, Amant, F, van den Broek, D & Lok, C A R 2022, ' Can serum human epididymis protein 4 (HE4) support the decision to refer a patient with an ovarian mass to an oncology hospital? ', Gynecologic Oncology, vol. 166, no. 2, pp. 284-291 . https://doi.org/10.1016/j.ygyno.2022.05.025
Gynecologic Oncology, 166(2), 284-291. Academic Press Inc.
Introduction: The value of serum human epididymis protein 4 (HE4) in guiding referral decisions in patients with an ovarian mass remains unclear, because the majority of studies investigating HE4 were performed in oncology hospitals. However, the dec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d0d18beb328af0949ebddd05d050205
https://pure.amc.nl/en/publications/can-serum-human-epididymis-protein-4-he4-support-the-decision-to-refer-a-patient-with-an-ovarian-mass-to-an-oncology-hospital(96633610-562f-4737-a937-774819dbd891).html
https://pure.amc.nl/en/publications/can-serum-human-epididymis-protein-4-he4-support-the-decision-to-refer-a-patient-with-an-ovarian-mass-to-an-oncology-hospital(96633610-562f-4737-a937-774819dbd891).html
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hermsen, B. B. J.1, Olivier, R. I.2, Verheijen, R. H. M.1, van Beurden, M.2, de Hullu, J. A.3, Massuger, L. F.3, Burger, C. W.4, Brekelmans, C. T.5, Mourits, M. J.6, de Bock, G. H.7, Gaarenstroom, K. N.8, van Boven, H. H.9, Mooij, T. M.10, Rookus, M. A.10 m.rookus@nki.nl
Publikováno v:
British Journal of Cancer. 5/7/2007, Vol. 96 Issue 9, p1335-1342. 8p. 1 Diagram, 1 Chart, 1 Graph.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lof P; Hospital for Gynecologic Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: p.lof@nki.nl., van de Vrie R; Hospital for Gynecologic Oncology Amsterdam, Amsterdam University Medical Hospital, Amsterdam, the Netherlands., Korse CM; Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Gent MDJM; Hospital for Gynecologic Oncology Amsterdam, Amsterdam University Medical Hospital, Amsterdam, the Netherlands., Mom CH; Hospital for Gynecologic Oncology Amsterdam, Amsterdam University Medical Hospital, Amsterdam, the Netherlands., Rosier-van Dunné FMF; Department of Gynecology, Tergooi Hospital, Blaricum and Hilversum, the Netherlands., van Baal WM; Department of Gynecology, Flevo Hospital, Almere, the Netherlands., Verhoeve HR; Department of Gynecology, OLVG, Amsterdam, the Netherlands., Hermsen BBJ; Department of Gynecology, OLVG, Amsterdam, the Netherlands., Verbruggen MB; Department of Gynecology, Zaans Medical Hospital, Zaandam, the Netherlands., Hemelaar M; Department of Gynecology, Dijklander Hospital, Hoorn and Purmerend, the Netherlands., van de Swaluw AMG; Department of Gynecology, Dijklander Hospital, Hoorn and Purmerend, the Netherlands., Knipscheer HC; Department of Gynecology, Spaarne Hospital, Haarlem and Hoofddorp, the Netherlands., Huirne JAF; Department of Gynecology, Amsterdam University Medical Hospital, Amsterdam, the Netherlands., Westenberg SM; Department of Gynecology, Noordwest Clinics, Alkmaar, the Netherlands., van der Noort V; Department of Statistics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Amant F; Hospital for Gynecologic Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Gynecologic Oncology, UZ Leuven, Leuven, Belgium., van den Broek D; Department of Laboratory Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lok CAR; Hospital for Gynecologic Oncology Amsterdam, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Gynecologic oncology [Gynecol Oncol] 2022 Aug; Vol. 166 (2), pp. 284-291. Date of Electronic Publication: 2022 Jun 08.
Autor:
Hermsen BB
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2007 Jun 16; Vol. 151 (24), pp. 1374; author reply 1374-5.